FY2025 · period end Dec '25 · from the 10-K filed Mar 25, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 |
|---|---|---|---|---|
| Revenue | $86.18B | $77.18B | $72.92B | — |
| Gross Profit | $11.30B | $11.59B | $7.97B | — |
| Operating Income | $4.16B | $4.38B | $1.08B | — |
| Net Income | — | — | — | — |
| EPS (Diluted) | $1.89 | $1.65 | negative: -$0.19 | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 |
|---|---|---|---|---|
| Total Assets | $45.16B | $40.69B | — | — |
| Total Liabilities | — | — | — | — |
| Stockholders' Equity | $9.52B | $8.13B | $9.71B | $9.55B |
| Cash & Equivalents | $4.57B | $5.61B | $4.57B | $2.53B |
| Total Debt | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 |
|---|---|---|---|---|
| Operating Cash Flow | $2.93B | $4.23B | $2.38B | — |
| Capital Expenditures | $2.10B | $1.48B | $1.50B | — |
| Free Cash Flow | $0.83B | $2.75B | $0.88B | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 |
|---|---|---|---|---|
| Gross Margin | 13.1% | 15.0% | 10.9% | — |
| Operating Margin | 0.0% | 0.1% | 1.5% | — |
| Net Margin | 0.1% | 0.1% | — | — |
| Return on Equity | — | 98.9% | — | — |
| Return on Assets | 18.6% | 19.8% | — | — |
| Debt / Equity | — | 2.38× | — | — |
Showing the most recent 4 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001213900-26-087444 | Aug 10, 2026 | Aug 11, 2026 | Aug 11, 2026 01:16 UTC | EDGAR |
| 10-Q | 0001791942-26-000004 | Jun 30, 2026 | Aug 10, 2026 | Aug 10, 2026 21:11 UTC | EDGAR |
| 20-F | 0001213900-26-034213 | Dec 31, 2025 | Mar 25, 2026 | Mar 25, 2026 21:30 UTC | EDGAR |
Direct links to SEC EDGAR. JBS has additional filings available on the SEC site.
One number JBS N.V. later changed — same XBRL tag, both filings linked.
TotalRevenue·FY 2024
Notable restatementwas$3.6B
Revised down in a 20-F. Any P/S built on the original was 3.5% too low.
JBS is not the only one.
See every restatement we've found across the market — or get an alert the next time JBS revises a number.
Restatements are detected by comparing every vintage of a fact across all of JBS N.V.'s filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows JBS's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling JBS N.V. — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on JBS yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on JBS and publish the result to your public profile.
Ask about JBS N.V.
Continue in Workspace — cited answers on JBS, a thesis you can score, or a signal on the next filing.
Open in WorkspaceGet 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs